The Effect of Prophylactic FFP Administration on ECMO Circuit Longevity

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

February 18, 2016

Study Completion Date

April 30, 2016

Conditions
Extracorporeal Membrane Oxygenation
Interventions
BIOLOGICAL

Fresh frozen plasma

Fresh frozen plasma is a pooled blood product containing both pro and anticoagulation factors. Patients enrolled in the intervention arm will receive scheduled fresh frozen plasma treatment every 48 hours. Patients in the control arm will receive fresh frozen plasma per current institutional standard of care. This includes supplementation for clotting/bleeding diatheses, volume replacement, or after 3 red blood cell transfusions in a 24 hour period.

Trial Locations (1)

27710

Duke University Medical Center PICU and PCICU, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER

NCT01903863 - The Effect of Prophylactic FFP Administration on ECMO Circuit Longevity | Biotech Hunter | Biotech Hunter